title: Laparoscopic anterior exenteration with intracorporeal uretero-sigmoidostomy.
abstract: OBJECTIVE
  To demonstrate the feasibility of laparoscopic anterior exenteration with intracorporeal ureterosigmoidostomy.
  
  
  METHODS
  After Institutional Review Board approval was obtained, patients who had undergone laparoscopic anterior exenteration with intracorporeal ureterosigmoidostomy were analyzed.
  
  
  METHODS
  Fifty-seven patients with advanced cervical carcinoma, stage IV A, since 2005 were analyzed retrospectively. The preoperative workup was done with contrast-enhanced computed tomography abdomen-pelvis and positron emission tomography (PET) scans. Patients were analyzed for operative time, blood loss, and complications. Patient follow-up was done monthly for the first 3 months, every 3 months for 1 year, and then every 6 months for 3 years. Postoperative follow-up was done with PET scans.
  
  
  METHODS
  Galaxy Care Laparoscopic Institute, Pune, India.
  
  
  METHODS
  Operative steps were as follows:
  
  
  RESULTS
  The mean operative time was 180 minutes (range, 140-240 minutes), and mean blood loss was 100 mL (range, 50-200 mL), as measured by the amount of blood in the suction machine. The median duration of hospital stay was 4 days (range, 3-7 days). The mean number of lymph nodes retrieved was 12 (range, 9-21). Surgical margins were negative in all patients with a lateral margin >2 cm. Twenty-eight patients had positive lymph nodes. Chemoradiotherapy was given to the patients with positive lymph nodes. Minor leak was present in 11 patients in the immediate postoperative period, for which no active intervention was required. Hyperchloremic metabolic acidosis which was seen on biochemical parameter but clinically patient have no manifestation and was treated with sodium bicarbonate. A postoperative PET scan was done at 6 months after the completion of adjuvant therapy in lymph node-positive patients and 6 months after surgery in node-negative patients.
  
  
  CONCLUSIONS
  Exenteration has a definitive role in the treatment of advanced cervical cancer. Results have demonstrated the feasibility of this procedure [1-4].
authors.affiliation: Maharashtra University Of Health Sciences, Nasik, Maharashtra, India. Electronic address: shase63@gmail.com.
authors.forename: A V
authors.initials: AV
authors.lastname: Jamkar
authors.affiliation: Galaxy Care Laparoscopy Institute, Pune, India.
authors.forename: Shailesh P
authors.initials: SP
authors.lastname: Puntambekar
authors.affiliation: Galaxy Care Laparoscopy Institute, Pune, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kumar
authors.affiliation: Galaxy Care Laparoscopy Institute, Pune, India.
authors.forename: Vikrant
authors.initials: V
authors.lastname: Sharma
authors.affiliation: Galaxy Care Laparoscopy Institute, Pune, India.
authors.forename: Saurabh
authors.initials: S
authors.lastname: Joshi
authors.affiliation: Galaxy Care Laparoscopy Institute, Pune, India.
authors.forename: Sainath
authors.initials: S
authors.lastname: Mitkare
mesh_terms: D059248:Chemoradiotherapy; D012809:Colon, Sigmoid / Q000473:pathology*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007194:India; D010535:Laparoscopy / Q000379:methods; D007902:Length of Stay; D008198:Lymph Nodes / Q000473:pathology; D049268:Positron-Emission Tomography; D012189:Retrospective Studies; D012811:Sigmoid Neoplasms / Q000473:pathology*; D014519:Ureterostomy; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000601:surgery
keywords: Advanced cervical cancer; Anterior exenteration; Ureterosigmoidostomy